explore our main Services
Biomarker Technologies provides ONE-STOP solutions on multi-omics levels that fulfill diverse research goals
Biomarker
Technologies
View MoreGO
Biomarker Technologies(BMKGENE) is an industry-leading genomics service provider, headquartered in Beijing. It has been actively engaged in innovation and developing high-throughput sequencing technologies and bioinformatics for over 13 years. With a passionate and highly-skilled R&D team , BMKGENE is committed to providing the most comprehensive sequencing services covering genomics, transcriptomics, single-cell omics and epigenetics.
why choose
Biomarker Technologies
- Our Platform
- BMKCloud
- Our Mission
Biomarker Technologies owns the most cutting-edge high-throughput sequencing platforms and high-performance computing platforms, serving for next-generation sequencing, third-generation sequencing, single-cell multiomics, proteomics, metabolomics and high-throughput data handling.
- Leading, Multi-level High-throughput Sequencing Platforms
- Professional, Automatic Molecular Laboratory
- Self-developed on-line bioinformatics analysis platform
Our outstanding technical team has robust ability in tackling scientific and technical issues and has accumulated massive experience in diverse research area and contributed in hundreds of high-impact publications in Nature, Nature Genetics, Nature Communications, Plant Cell, etc. It owns over 60 nation patents of inventions and 200 software copyrights.
- Science and Technology Services
- On-line Bioinformatics Platform
- Medical Technology Services
Biomarker Technologies is committed to continuously creat greater value for its customers and lead the industrial transformation with high-quality innovations to realize its ultimate mission of benefiting humanity with genetic technology.
- To innovate biotechnology
- To Serve the society
- To Benefit people
- To create innovative biotechnology center and establish a symbolic enterprise in bio-industry
We’Ll Provide You With
Professional Services
-
500 Professional Staff
It has a R & D team of more than 500 highly educated technicians. -
60 Nation Patents of Inventions
It owns over 60 nation patents of inventions. -
200 Software Copyrights
It owns over 200 software copyrights. -
9000+ Impact Factor
Biomarker Technologies has contributed to over 1000 high-impact published projects.
Our Platforms
Inquiry
For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.
Inquiry nowNews & Highlights
view more-
ASHG 2024 – The Ameri...
We are excited to announce that BMKGENE will be participating in the American Society of Human Genetics (ASHG) 2024 conference, taking place from November 5th to 9th at the Colorado Convention Cen...read more -
ASM Microbe 2024 — American...
ASM Microbe 2024 is coming. As a company dedicated to exploring the mysteries of genes and providing the forefront biotechnology services, BMKGENE hereby officially announces that we will b...read more -
EACR 2024 — The European As...
EACR2024 is about to open in Rotterdam Netherlands at June 10th-13th. As service provider in the field of biotechnology, BMKGENE will bring elite attendees to the feast of multi-omics sequencing ...read more